Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial. Carausu M, Neven P, Ignatiadis M. Ann Oncol 2025;36:127-129.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Carausu M, Neven P, Ignatiadis M. Expanding the role of CDK4/6 inhibitors in early breast cancer: insights from the NATALEE trial. Ann Oncol 2025;36:127-129.
PMID: 39880556